Table 4.

Tofacitinib effective and remission rates for moderate to severe ulcerative colitis in real-world data

Country	year	N	2 weeks (%)		4 weeks (%)		8 weeks (%)		12 weeks (%)		14 weeks (%)		16 weeks (%)		24 weeks (%)
			Effective	Remission	Effective	Remission	Effective	Remission	Effective	Remission	Effective	Remission	Effective	Remission	Effective	Remission
Germany14	2020	38					47.4	28.9							36.1	19.4
Japan15	2021	30			40	20	47	40	50	43					45	41
France16	2020	38									44.8	31.6			36.9	31.6
Spain17	2021	113			40	16	60	31					57	32
This study	2021	18	55.5	22.2			38.8	33.3					38.8	38.8